1. Armstrong P.W., Gershlick A.H., Goldstein P., Wilcox R., Danays T., Lambert Y. et al. STREAM investigative team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N. Engl. J. Med. 2013; 15: 1379-87.
2. Bhatt N.S., Solhpour A., Balan P., Barekatain A., McCarthy J.J., Sdringola S. et al. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am. J. Cardiol. 2013; 111: 1576-9.
3. Miguel-Balsa E., Latour-Pérez J., Baeza-Roman A., Llamas-Alvarez A., Ruiz-Ruiz J. et al. Accessibility to reperfusion therapy among women with acute myocardial infarction: impact on hospital mortality. J. Womens Hlth (Larchmt). 2015; 24: 882-8.
4. Otten A.M., Maas A.H., Ottervanger J.P., Kloosterman A., van't Hof A.W., Dambrink J.H. et al. Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. Zwolle Myocardial Infarction study Group. Eur. Heart J. Acute Cardiovasc. Care. 2013; 4: 334-41.
5. Chieffo A., Buchanan G.L., Mauri F., Mehilli J., Vaquerizo B., Moynagh A. et al. ACS and STEMI treatment: gender-related issues. EuroIntervention. 2012; 8: 27-35.